updated 4/13/2004 8:58:34 AM ET 2004-04-13T12:58:34

Barbara J. Michal’s son died in 1997, one of dozens of people whose deaths are linked to the once-popular diet drug ephedra.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

So she praised a federal judge’s decision Monday to allow a nationwide ban on dietary supplements containing ephedra to take effect. The ruling turned aside a plea from two manufacturers.

“It’s got to stop,” said Michal, of Riverside, Calif. “This is not about public health and science. It’s about politics and money.”

U.S. District Judge Joel Pisano refused to grant a temporary restraining order that would have prevented the Food and Drug Administration from banning the products.

Supplement linked to 155 deaths
Ephedra, once hugely popular for weight loss and bodybuilding, has been linked to 155 deaths, including that of Baltimore Orioles pitcher Steve Bechler a year ago.

After years of fighting manufacturers over the risks, the FDA announced in December that it was banning the sale of the amphetamine-like herb — the first such ban of a dietary supplement.

“These products pose unacceptable health risks, and any consumers who are still using them should stop immediately,” Health and Human Services Secretary Tommy G. Thompson said.

NVE Pharmaceuticals of Newton, manufacturer of the diet supplement Stacker 2, had hoped to head off the ban, arguing its product is safe if used as directed. It was joined by a second company, the National Institute for Clinical Weight Loss, manufacturer of a product called Thermalean.

The judge said the manufacturers did not meet several legal requirements, including proving that they are likely to win the case and that they would suffer irreparable harm if the ban took effect.

Pisano’s ruling means the ban will be in effect at least until NVE’s lawsuit can be heard. No trial date has been set.

The ban does not affect decongestants and other medicines containing ephedrine, a synthetic version of ephedra. Drugs containing ephedrine and a chemical cousin called pseudoephedrine are regulated and approved by the FDA and are safe, said agency spokesman Lawrence Bachorik.

Ephedra sales already had plummeted because of publicity about the risks, especially after Bechler’s death a year ago. Three states — New York, Illinois and California — prohibited the stimulant on their own.

“Ephedra has killed more than 100 individuals and injured thousands of others,” said Bruce Silverglade, legal director of the Washington-based Center for Science in the Public Interest. “The only problem is, it took the FDA almost 10 years to ban the substance.”

Unlike medications, which must be proven safe and effective before they are allowed to be sold, federal law allows dietary supplements to be marketed without any such proof. To curb a supplement, the FDA must show it poses a significant health threat.

NVE maintains that the FDA failed to prove such a threat if the supplement is taken correctly, and was swayed by the outcry over ephedra deaths.

“The FDA chose to ignore valid science that showed that there wasn’t a problem,” said Walter Timpone, a lawyer for NVE. “In 1999, (there were) 104 deaths as a result of aspirin ingestion. Are we going to ban aspirin now?”

© 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments